The following post is in reference to paper tilted: link: https://alz-journals.onlinelibrary.wiley.com/doi/10.1016/j.jalz.2010.03.018 The purpose of this paper is to establish realtionship between covariates like baseline severity, age, APOE4 genotype and gender, and the slope of yearly decline in ADAS-Cog cognition measure. The Conclusions Most Relevant To Investors: The mean slope is dependent mostly on baseline severity … Continue reading Why Placebo Arm Is Critical To Proper Assesment Of Therapeutic Effect In Trials Of Alzheimer’s Disease. The Case of Phase2b/3 For Blarcamesine (Anavex2-73) And Simufilam Open Label. $AVXL $SAVA